The majority of the antimalarial products on sale in Kenya are neither brands nor generics but copy products of unknown provenance and variable quality.

Innovation by India's internationally competitive scientists suffersfrom the Indian government'sprotectionist policies.

Whenever the Thai government defiesforeign drug patents and creates its own cheap copies of drugs, it endangers the patients who need the drugs and undermines drug discovery.

Many malaria sufferers are receiving unsafe, low-quality drugs. The FDA and the Global Fund must act to change this.

Myriad responses are required for all parts of the substandard drug problem.

Today, nearly 80 percent of active pharmaceutical ingredients originate outside the United States. But the FDA cannot adequately oversee the safety of chemicals manufactured overseas and imported into the United States.

Americans should be permitted to buy medicines online for personal use; there are many sites providing good quality medicines at low prices, and importation for personal use is not likely to undermine the pharmaceutical market.

The Canadian Government may think it is helping poor Africans when it allows drugs to be copied.